| New kind of antiretroviral, KP-1461; clinical trial recruiting. Interview with Stephen Becker, M.D. | |
| | |
MedLine Citation:
|
PMID: 18411488 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
KP-1461, an experimental HIV drug already in a phase II trial, works so differently from other antiretrovirals that at first glance it looked like science fiction, and we found it hard to take seriously as a current possibility today. In fact this drug is highly credible, and based on elegant science that goes back at least 25 years. KP-1461 is the only antiretroviral in human use or testing that can eradicate HIV from laboratory cell cultures. No one knows how it will work in people -- but we might know by the second quarter of 2008, when the current phase II trial could be complete. AIDS Treatment News interviewed Dr. Stephen Becker, a leading AIDS physician and researcher who is vice president of clinical development at Koronis Pharmaceuticals, in Seattle, Washington. |
| | |
Authors:
|
Stephen Becker |
Related Documents
:
|
11953338 - Clinical and economic consequences of dyspepsia in the community. 3767218 - Perilymphatic fistula: a histopathologic study. 4041198 - Methods of randomization in controlled clinical trials. 3351808 - Problem visits to a family planning clinic. 15861228 - Distribution, spread, and ecological associations of the introduced ant pheidole obscur... 12941518 - Methods, architecture, evaluation and usability of a case-based antibiotics advisor. |
Publication Detail:
|
Type: Interview; Newspaper Article |
Journal Detail:
|
Title: AIDS treatment news Volume: - ISSN: 1052-4207 ISO Abbreviation: AIDS Treat News Publication Date: 2007 Jul-Sep |
Date Detail:
|
Created Date: 2008-04-07 Completed Date: 2008-05-05 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8809835 Medline TA: AIDS Treat News Country: United States |
Other Details:
|
Languages: eng Pagination: 3-7 Citation Subset: X |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Anti-HIV Agents
/
therapeutic use* Clinical Trials as Topic HIV Infections / drug therapy* Humans Nucleosides / therapeutic use* |
| Chemical | |
Reg. No./Substance:
|
0/Anti-HIV Agents; 0/KP 1461; 0/Nucleosides |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Optimization of the program of complex perioperative treatment of patients with advanced purulent pe...
Next Document: Elevated serum polybrominated diphenyl ethers and thyroid-stimulating hormone associated with lympho...